Drug Cuts Death Risk for Melanoma Patients With BRAF Mutation

nasher

stumbled across this not sure if it is relitive to thyroid cancer BRAF mutation but thought this might be a good read

Aug. 17, 2011 -- The FDA today approved Zelboraf, a drug that can extend survival for the 50% of melanoma patients whose tumors carry the BRAF V600E mutation.



http://www.webmd.com/melanoma-skin-cancer/news/20110817/zelboraf-approved-for-late-stage-melanoma

any increase of survivaly rate of any cancer is happy